BBR Partners’s Celgene Corp CELG Stock Holding History

BBR Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,000	Closed	-$627K	–	89
2016 Q3	$627K	Buy	+6,000	New	+$649K	0.1%	34

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBR Partners's CELG Position: Q4 2016 in Review

BBR Partners sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 6,000 shares — an estimated $627K sold.

BBR Partners first reported a position in CELG in Q3 2016 and held it in 1 quarter. The position peaked at $627K in Q3 2016. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

BBR Partners reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
BBR Partners sold 6,000 Celgene Corp shares in Q4 2016, an estimated $627K.
BBR Partners first reported a position in Celgene Corp in Q3 2016 and held it in 1 quarter.
BBR Partners's Celgene Corp position peaked at $627K in Q3 2016.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on BBR Partners's 13F filing for Q4 2016, filed 10 Feb 2017.